Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 8,396 | 8,598 | 7,855 | 7,855 | 9,536 |
| Operating Income | -8,396 | -8,598 | -7,855 | -7,855 | -9,536 |
| Interest Expense | 749 | 758 | 750 | 722 | 689 |
| Other Income | 311 | 226 | 302 | 213 | 211 |
| Pre-tax Income | -8,834 | -9,130 | -8,303 | -8,364 | -10,014 |
| Net Income Continuous | -8,834 | -9,130 | -8,303 | -8,364 | -10,014 |
| Net Income | $-8,834 | $-9,130 | $-8,303 | $-8,364 | $-10,014 |
| EPS Basic Total Ops | -2.16 | -2.91 | -3.25 | -4.25 | -5.96 |
| EPS Basic Continuous Ops | -2.16 | -2.68 | -3.36 | -4.37 | -5.96 |
| EPS Diluted Total Ops | -2.16 | -2.91 | -3.25 | -4.25 | -5.96 |
| EPS Diluted Continuous Ops | -2.16 | -2.68 | -3.36 | -4.37 | -5.96 |
| EPS Diluted Before Non-Recurring Items | -2.16 | -3.42 | -3.25 | -4.25 | -6.00 |
| EBITDA(a) | $-8,428 | $-8,669 | $-8,004 | $-7,906 | $-9,627 |